Correlation Between Mineralys Therapeutics, and Oric Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Oric Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Oric Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Oric Pharmaceuticals, you can compare the effects of market volatilities on Mineralys Therapeutics, and Oric Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Oric Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Oric Pharmaceuticals.
Diversification Opportunities for Mineralys Therapeutics, and Oric Pharmaceuticals
-0.27 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Mineralys and Oric is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Oric Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oric Pharmaceuticals and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Oric Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oric Pharmaceuticals has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Oric Pharmaceuticals go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and Oric Pharmaceuticals
Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to generate 0.96 times more return on investment than Oric Pharmaceuticals. However, Mineralys Therapeutics, Common is 1.05 times less risky than Oric Pharmaceuticals. It trades about 0.06 of its potential returns per unit of risk. Oric Pharmaceuticals is currently generating about 0.06 per unit of risk. If you would invest 807.00 in Mineralys Therapeutics, Common on August 25, 2024 and sell it today you would earn a total of 442.00 from holding Mineralys Therapeutics, Common or generate 54.77% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. Oric Pharmaceuticals
Performance |
| Timeline |
| Mineralys Therapeutics, |
| Oric Pharmaceuticals |
Mineralys Therapeutics, and Oric Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and Oric Pharmaceuticals
The main advantage of trading using opposite Mineralys Therapeutics, and Oric Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Oric Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oric Pharmaceuticals will offset losses from the drop in Oric Pharmaceuticals' long position.| Mineralys Therapeutics, vs. Eliem Therapeutics | Mineralys Therapeutics, vs. HCW Biologics | Mineralys Therapeutics, vs. RenovoRx | Mineralys Therapeutics, vs. Scpharmaceuticals |
| Oric Pharmaceuticals vs. Seer Inc | Oric Pharmaceuticals vs. Anebulo Pharmaceuticals | Oric Pharmaceuticals vs. Cullinan Oncology LLC | Oric Pharmaceuticals vs. C4 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |